X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with Piramal Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs PIRAMAL ENTERPRISES - Comparison Results

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA PIRAMAL ENTERPRISES ALEMBIC PHARMA/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 26.4 35.9 73.6% View Chart
P/BV x 6.0 3.6 168.5% View Chart
Dividend Yield % 0.8 0.7 115.0%  

Financials

 ALEMBIC PHARMA   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
PIRAMAL ENTERPRISES
Mar-16
ALEMBIC PHARMA/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs7921,065 74.3%   
Low Rs443805 55.0%   
Sales per share (Unadj.) Rs167.0383.0 43.6%  
Earnings per share (Unadj.) Rs38.255.1 69.3%  
Cash flow per share (Unadj.) Rs42.074.1 56.7%  
Dividends per share (Unadj.) Rs4.0017.50 22.9%  
Dividend yield (eoy) %0.61.9 34.6%  
Book value per share (Unadj.) Rs84.9719.9 11.8%  
Shares outstanding (eoy) m188.52172.56 109.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.72.4 151.4%   
Avg P/E ratio x16.217.0 95.3%  
P/CF ratio (eoy) x14.712.6 116.5%  
Price / Book Value ratio x7.31.3 559.8%  
Dividend payout %10.531.8 33.0%   
Avg Mkt Cap Rs m116,383161,344 72.1%   
No. of employees `000NA3.8 0.0%   
Total wages/salary Rs m4,21416,898 24.9%   
Avg. sales/employee Rs ThNM17,472.6-  
Avg. wages/employee Rs ThNM4,466.9-  
Avg. net profit/employee Rs ThNM2,512.8-  
INCOME DATA
Net Sales Rs m31,48766,099 47.6%  
Other income Rs m552,425 2.3%   
Total revenues Rs m31,54268,524 46.0%   
Gross profit Rs m10,06018,723 53.7%  
Depreciation Rs m7223,274 22.1%   
Interest Rs m379,388 0.4%   
Profit before tax Rs m9,3568,485 110.3%   
Minority Interest Rs m03 0.0%   
Prior Period Items Rs m-21,593 -0.1%   
Extraordinary Inc (Exp) Rs m0457 0.0%   
Tax Rs m2,1601,032 209.3%   
Profit after tax Rs m7,1949,506 75.7%  
Gross profit margin %31.928.3 112.8%  
Effective tax rate %23.112.2 189.9%   
Net profit margin %22.814.4 158.9%  
BALANCE SHEET DATA
Current assets Rs m15,06647,488 31.7%   
Current liabilities Rs m7,674104,362 7.4%   
Net working cap to sales %23.5-86.0 -27.3%  
Current ratio x2.00.5 431.4%  
Inventory Days Days6741 164.9%  
Debtors Days Days4151 79.4%  
Net fixed assets Rs m8,23726,532 31.0%   
Share capital Rs m377345 109.2%   
"Free" reserves Rs m15,416114,024 13.5%   
Net worth Rs m16,005124,221 12.9%   
Long term debt Rs m075,812 0.0%   
Total assets Rs m24,594308,356 8.0%  
Interest coverage x255.21.9 13,406.5%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.30.2 597.3%   
Return on assets %29.46.1 479.9%  
Return on equity %44.97.7 587.4%  
Return on capital %58.710.0 589.0%  
Exports to sales %55.717.2 324.3%   
Imports to sales %10.46.6 157.9%   
Exports (fob) Rs m17,55111,362 154.5%   
Imports (cif) Rs m3,2834,364 75.2%   
Fx inflow Rs m17,81114,435 123.4%   
Fx outflow Rs m5,3185,183 102.6%   
Net fx Rs m12,4939,253 135.0%   
CASH FLOW
From Operations Rs m9,304-67,773 -13.7%  
From Investments Rs m-3,105-8,768 35.4%  
From Financial Activity Rs m-1,95976,199 -2.6%  
Net Cashflow Rs m4,240-342 -1,238.3%  

Share Holding

Indian Promoters % 74.1 52.9 140.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 4.0 72.5%  
FIIs % 9.1 26.6 34.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 16.5 84.2%  
Shareholders   49,328 93,274 52.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   BIOCON LTD  CADILA HEALTHCARE  VENUS REMEDIES  PLETHICO PHARMA  GLENMARK PHARMA  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Energy Stocks Witness Buying(11:30 am)

After opening the day in green, Share markets in India witnessed volatile trading activity and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Aug 22, 2017 12:47 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS